vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $31.1M, roughly 1.1× LIFECORE BIOMEDICAL, INC. \DE\). Clearfield, Inc. runs the higher net margin — -1.8% vs -32.1%, a 30.3% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-2.4M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CLFD vs LFCR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $31.1M |
| Net Profit | $-614.0K | $-10.0M |
| Gross Margin | 33.2% | 25.0% |
| Operating Margin | -5.3% | -9.9% |
| Net Margin | -1.8% | -32.1% |
| Revenue YoY | -3.2% | -4.5% |
| Net Profit YoY | 67.8% | -52.0% |
| EPS (diluted) | $-0.04 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | — | ||
| Q3 25 | $23.4M | $31.1M | ||
| Q2 25 | $49.9M | — | ||
| Q1 25 | $47.2M | $35.2M | ||
| Q4 24 | $29.7M | $32.6M | ||
| Q3 24 | $5.6M | $24.7M | ||
| Q2 24 | $48.8M | — | ||
| Q1 24 | $36.9M | $35.7M |
| Q4 25 | $-614.0K | — | ||
| Q3 25 | $-9.1M | $-10.0M | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.3M | $-14.8M | ||
| Q4 24 | $-1.9M | $-6.6M | ||
| Q3 24 | — | $-16.2M | ||
| Q2 24 | $-447.0K | — | ||
| Q1 24 | $-5.9M | $15.6M |
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | 25.0% | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | 28.0% | ||
| Q4 24 | 29.2% | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | 33.3% |
| Q4 25 | -5.3% | — | ||
| Q3 25 | 10.3% | -9.9% | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 0.6% | -25.7% | ||
| Q4 24 | -6.9% | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | -26.4% | -2.5% |
| Q4 25 | -1.8% | — | ||
| Q3 25 | -38.8% | -32.1% | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 2.8% | -42.0% | ||
| Q4 24 | -6.4% | -20.2% | ||
| Q3 24 | — | -65.7% | ||
| Q2 24 | -0.9% | — | ||
| Q1 24 | -16.0% | 43.8% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.65 | $-0.29 | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.09 | $-0.47 | ||
| Q4 24 | $-0.13 | $-0.25 | ||
| Q3 24 | — | $-0.53 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.40 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $249.7M | $-10.5M |
| Total Assets | $268.1M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | — | ||
| Q3 25 | $106.0M | $18.9M | ||
| Q2 25 | $117.2M | — | ||
| Q1 25 | $112.0M | $5.4M | ||
| Q4 24 | $113.0M | $9.5M | ||
| Q3 24 | $129.0M | — | ||
| Q2 24 | $123.8M | — | ||
| Q1 24 | $142.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | $2.2M | $106.3M | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $249.7M | — | ||
| Q3 25 | $256.2M | $-10.5M | ||
| Q2 25 | $264.5M | — | ||
| Q1 25 | $265.9M | $2.2M | ||
| Q4 24 | $267.4M | $15.4M | ||
| Q3 24 | $275.8M | $-3.9M | ||
| Q2 24 | $274.6M | — | ||
| Q1 24 | $279.2M | $17.7M |
| Q4 25 | $268.1M | — | ||
| Q3 25 | $306.2M | $235.2M | ||
| Q2 25 | $314.7M | — | ||
| Q1 25 | $310.9M | $237.7M | ||
| Q4 24 | $303.2M | $255.4M | ||
| Q3 24 | $315.3M | $246.8M | ||
| Q2 24 | $318.1M | — | ||
| Q1 24 | $315.4M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $1.8M |
| Free Cash FlowOCF − Capex | $-2.4M | $25.0K |
| FCF MarginFCF / Revenue | -7.1% | 0.1% |
| Capex IntensityCapex / Revenue | 2.9% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | — | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $3.0M | $1.2M | ||
| Q4 24 | $7.2M | $-6.1M | ||
| Q3 24 | $22.2M | $-613.0K | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $-5.7M | $-1.4M |
| Q4 25 | $-2.4M | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $654.0K | $-4.3M | ||
| Q4 24 | $5.1M | $-8.6M | ||
| Q3 24 | $18.2M | $-4.0M | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $-7.7M | $-7.8M |
| Q4 25 | -7.1% | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 1.4% | -12.1% | ||
| Q4 24 | 17.1% | -26.3% | ||
| Q3 24 | 323.0% | -16.3% | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | -20.8% | -21.8% |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.0% | 5.6% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 5.1% | 15.5% | ||
| Q4 24 | 7.0% | 7.5% | ||
| Q3 24 | 71.4% | 13.9% | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 5.3% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
